GPO contract purchase for lab

McKesson was awarded a General Services Administration (GSA) contract by the State of Texas (Contract ID: HHSTX-6-0000395081) on February 11, 2026, for the provision of pharmaceuticals and allergenic extracts to support laboratory operations. The contract encompasses multiple therapeutic and diagnostic products classified under NIGP Code 26972 (Miscellaneous Drugs and Pharmaceuticals). Specific products include allergenic extracts derived from alfalfa, horse epithelium, and alder, along with pharmaceutical agents including Vestronidase alfa and Naloxegol.

The contract addresses laboratory pharmaceutical procurement needs within Texas. While specific contract values, cumulative amounts, and the exact period of performance are not specified in the available documentation, the award represents a GPO (Group Purchasing Organization) contract purchase arrangement. The scope of supply encompasses both diagnostic materials for allergenic testing and pharmaceutical products for therapeutic use, reflecting a comprehensive laboratory pharmaceutical support function.